Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272176 · ClinicalTrials.gov registry record · NA
Veterans Coordinated Community Care (3C) Study
A NA study of Suicide, sponsored by Brown University.
- Active
- Registry status
- NA
- Development phase
- 850
- Enrollment target
- 7
- Study locations
NCT05272176: Active NA study of Suicide, sponsored by Brown University.
NCT05272176 is a NA study of Suicide that is active but no longer recruiting, run by Brown University. The registered enrollment target is 850 participants, below the 6,981-participant average among 92 other Suicide trials with a reported enrollment target (88% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05272176, a NA study of Suicide, is active but no longer recruiting, sponsored by Brown University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 850 participants
- Enrollment target
- 7
- Study locations
Study Summary
Veterans Coordinated Community Care (3C) Study will recruit 850 Veterans at risk for suicide post inpatient hospitalization. Each participant will be randomly assigned to treatment as usual (TAU) or TAU plus the Coping Long Term with Active Suicide Program (CLASP), with follow-up for 6 months after discharge. Outcomes include suicide-related behaviors (including deaths due to suicide, opioid overdose, or other substance-related accidents; and nonfatal suicide attempts) and suicidal ideation and functioning.
Primary Outcome
Suicide related behaviors that include deaths due to suicide, opioid overdose, or other substance-related accidents; and nonfatal suicide attempts.
Conditions Studied
Interventions
- BEHAVIORAL Coping Long Term with Active Suicide Program (CLASP)
Study Locations (7)
Arkansas
- Central Arkansas Veterans Healthcare System - Little Rock
Massachusetts
- VA Boston Healthcare System - Boston
Minnesota
- Minneapolis VA Health Care System - Minneapolis
Missouri
- VA St. Louis Health Care System - St Louis
Pennsylvania
- VA Pittsburgh Healthcare System - Pittsburgh
Tennessee
- VA Tennessee Valley Health Care System - Murfreesboro
Texas
- VA North Texas Healthcare System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2022-01-11 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05272176 still lists
NCT05272176 is an interventional study that assigns participants to a tested intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, below the 6,981-participant average among 92 other Suicide trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Coping Long Term with Active Suicide Program (CLASP) is the first listed.
NCT05272176 lists 7 locations in 7 states (Arkansas, Massachusetts, Minnesota).
Frequently Asked Questions
What is clinical trial NCT05272176 about?
NCT05272176 is a clinical study titled "Veterans Coordinated Community Care (3C) Study". Veterans Coordinated Community Care (3C) Study will recruit 850 Veterans at risk for suicide post inpatient hospitalization. Each participant will be randomly assigned to treatment as usual (TAU) or TAU plus the Coping Long Term with Active Suicide Program (CLASP), with follow-up for 6 months after ...
What is the current status of trial NCT05272176?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 850 participants. The study started on 2022-01-11. Estimated completion is 2026-06-30.
What conditions does trial NCT05272176 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT05272176?
The interventions under investigation include: Coping Long Term with Active Suicide Program (CLASP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05272176?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05272176 being conducted?
This trial has 7 study locations across Arkansas, Massachusetts, Minnesota, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05272176's enrollment target sits among peer trials
850 17th of 92 higher than 76 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
- NCT05987059 · 850 participants · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
- NCT06289673 · 850 participants · Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI